Art Gilliland
Chief Executive Officer at Delinea, Inc. (United States)
Network origin in Art Gilliland first degree
Entity | Entity type | Industry | |
---|---|---|---|
Delinea, Inc. (United States)
Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ.
2
| Subsidiary | Biotechnology | 2 |
Delinea Corp.
Delinea Corp. Information Technology ServicesTechnology Services Delinea Corp. provides information technology, outsourcing and consulting services for the energy and utility industries. Its services include outsourcing and service hosting, business development, consulting, training and support. The company also provides infrastructure management, asset management and project management. The firm was founded by Kevin Wright in April, 2000 and is located in Delinea, TX.
1
| Subsidiary | Information Technology Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Art Gilliland via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Biotechnology | Director/Board Member | |
Centrify Corp.
Centrify Corp. Packaged SoftwareTechnology Services Centrify Corp. provides identity management software solutions. Its solutions include secure cloud and on-premises apps, multi-factor authentication, privileged access management, secure hybrid cloud, big data security, risk-based access control, and secure develops. The firm also offers application, endpoint, infrastructure, analytics, and federal CAC reader platform services to automotive and energy, banking and finance, defense and government, education, internet and entertainment, manufacturing and construction, and pharma and health industries. The company was founded by Thomas R. Kemp, Paul Moore and Adam W. Au in 2004 and is headquartered in Santa Clara, CA. | Packaged Software | President | |
Onapsis, Inc.
Onapsis, Inc. Packaged SoftwareTechnology Services Onapsis, Inc. provides solutions for securing SAP and oracle enterprise applications. It offers Onapsis Security Platform, a SAP-certified cyber-security solution that combines a preventative, behavioural-based, and context-aware approach for detecting, identifying, and mitigating security risks, compliance gaps, and cyber-attacks on business-critical applications. The firms services includes business risk illustration, penetration testing of SAP and oracle systems and security audits of SAP system services. The company was founded by Mariano Nunez and Victor Hugo Montero in 2009 and is headquartered in Boston, MA. | Packaged Software | Chief Operating Officer | |
RSA Security LLC
RSA Security LLC Miscellaneous Commercial ServicesCommercial Services RSA Security LLC designs and develops support security products. The firm offers threat detection and response, identity and access management, fraud prevention, and cyber security framework. The company was founded in 1984 and is headquartered in Bedford, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BRIGHTCOVE INC. | Internet Software/Services | Corporate Officer/Principal | |
CA TECHNOLOGIES | Packaged Software | Sales & Marketing | |
Skyport Systems LLC
Skyport Systems LLC Packaged SoftwareTechnology Services Skyport Systems, Inc. develops hyper-secured infrastructure that ensures the security of mission-critical IT and corporate assets with integration of compute, security, virtualization and policy management. Its products include SkySecure Compartments, SkySecure Systems, and SkySecure Center. The company was founded by Michael Beesley, William N. Eatherton and Rob Rodgers in 2013 and is headquartered in Mountain View, CA. | Packaged Software | Sales & Marketing | |
Muna Therapeutics ApS
Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member | |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Biotechnology | Director/Board Member | |
Nitrase Therapeutics, Inc.
Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Miscellaneous Commercial Services | Director/Board Member | |
Comet Therapeutics, Inc.
Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor | |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Chief Investment Officer | |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Director/Board Member | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Affinicon ApS
Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark. | Pharmaceuticals: Major | Chairman | |
Avilex Pharma ApS
Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member | |
EpiTherapeutics ApS
EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member | |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chief Investment Officer | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member | |
University of Copenhagen | College/University | Doctorate Degree | |
Advanced Cyber Security Center | Director/Board Member |
Statistics
International
Denmark | 12 |
United States | 12 |
United Kingdom | 2 |
France | 2 |
Germany | 2 |
Sectoral
Health Technology | 14 |
Technology Services | 6 |
Finance | 5 |
Commercial Services | 3 |
Health Services | 2 |
Operational
Director/Board Member | 16 |
Chairman | 4 |
President | 3 |
Private Equity Investor | 2 |
Chief Investment Officer | 2 |
Most connected contacts
Insiders | |
---|---|
Henrijette Richter | 21 |
Rick Hanson | 9 |
- Stock Market
- Insiders
- Art Gilliland
- Company connections